FLCNX
Price
$34.94
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Net Assets
35.94B
GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

FLCNX vs GFACX

Header iconFLCNX vs GFACX Comparison
Open Charts FLCNX vs GFACXBanner chart's image
Fidelity Contrafund K6
Price$34.94
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets35.94B
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
FLCNX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FLCNX vs. GFACX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCNX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. FLCNX (35.9B). FLCNX pays higher dividends than GFACX: FLCNX (0.24) vs GFACX (0.00). FLCNX was incepted earlier than GFACX: FLCNX (8 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FLCNX (0.45). GFACX is a more actively managed with annual turnover of: 25.00 vs. FLCNX (19.00). FLCNX has a lower initial minimum investment than GFACX: FLCNX (0) vs GFACX (250). FLCNX annual gain was more profitable for investors over the last year : 18.07 vs. GFACX (7.11). FLCNX return over 5 years is better than : 117.24 vs. GFACX (35.91).
FLCNXGFACXFLCNX / GFACX
Total Expense Ratio0.451.3633%
Annual Report Gross Expense Ratio0.451.3633%
Fund Existence8 years24 years-
Gain YTD12.38311.292110%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets35.9B323B11%
Annual Yield % from dividends0.240.00-
Returns for 1 year18.077.11254%
Returns for 3 years107.1252.01206%
Returns for 5 years117.2435.91326%
Returns for 10 yearsN/A63.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp